Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
There is a long report today on Bloomberg.com about the risks from infection associated with prostate biopsy. This is a topic that The “New” Prostate Cancer InfoLink has cautioned about previously, and it is increasingly a risk that needs to be taken seriously.
Filed under: Diagnosis, Risk | Tagged: biopsy, infection, mortality, sepsis | 16 Comments »
A question that comes up all the time is whether there is any direct (i.e., cause and effect) association between prostate “inflammation” and a subsequent diagnosis of prostate cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Arnon Krongrad MD, benign prostatic hyperplasia, BPH, cause, chronic prostatitis, inflammation, prostatitis, Shenghan Lai | Leave a Comment »
We are sorry to note that, as of May 6, 2011, the formerly free UroToday service has converted to a for-profit subscription service that is likely to be beyond the means of the average patient.
Filed under: Uncategorized | 6 Comments »
A new Canadian study just reported in the Journal of Clinical Oncology has failed to find any significant benefit from the use of vitamin E, selenium, and soy protein supplements in the prevention of prostate cancer.
Filed under: Diagnosis, Prevention, Risk | Tagged: HG-PIN, high-grade, Prevention, prostatic intraepithelial neoplasia, risk, selenium, soy, vitamin E | 5 Comments »
Bill-Axelson et al. have reported a second update to the results of the Scandinavian trial of radical prostatectomy (RP) compared to watchful waiting in patients with “early” (but not necessarily localized) prostate cancer
Filed under: Management, Treatment | Tagged: outcome, radical prostatectomy, watchful waiting | 6 Comments »
Please take just 5 minutes to write your Congressman or Congresswoman and ask him or her to continue to support and protect funding for the Department of Defense’s Prostate Cancer Research Program (PCRP). We need your help before May 12. Just click on the link above to use the ZERO CapWiz program.
Filed under: Uncategorized | Tagged: advocacy, funding, PCRP | Leave a Comment »
A recently published study reports on the incidence of PSA testing in the United Kingdom (UK) in 2007. There is no national recommendation for prostate cancer testing (i.e., “screening”) in the UK. However, PSA testing is covered by National Health Service; men who request a PSA test will normally be given one by their family doctor.
Filed under: Diagnosis, Risk | Tagged: risk, screening, testing, UK | 1 Comment »
Exactly how some of the major, tertiary, specialized prostate cancer centers think about the management of prostate cancer over time needs to be taken into account in evaluation of the data being published by those centers.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: active surveillance, risk, shift, stage, surgery | Leave a Comment »
YK-4-279 is an investigational agent that is already in development for treatment of a form of childhood cancer known as Ewing’s sarcoma. However, laboratory studies have now shown that this drug may also have potential in the treatment of progressive forms of prostate cancer.
Filed under: Drugs in development | Tagged: YK-4-279 | Leave a Comment »
According to a media release issued by Fox Chase Cancer Center yesterday, researchers at this institution have been able to demonstrate that “aspirin reduces the risk of cancer recurrence in some prostate cancer patients.”
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: aspirin, outcome, radiation therapy, recurrence | Leave a Comment »
Data from the Cleveland Clinic offer some insight into the medium- and long-term outcomes of a cohort of men initially diagnosed between January 1998 and June 2004 with high-risk, localized prostate cancer and treated by radical prostatectomy alone as their first-line therapy.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: "high risk", outcome, radical prostatectomy | 2 Comments »
An interesting study presented at the European Association of Urology meeting in Vienna recently documented risk for prostate cancer-specific and other forms of mortality within 15 years of diagnosis for Swedish men initially diagnosed with low- and intermediate-risk prostate cancer.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: mortality, risk, Sweden | 4 Comments »
According to a media release issued last Friday, “A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy.”
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: DCE, dynamic contrast-enhanced, emdorectal, MRI, radiation therapy, salvage | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site